Palo Santo

Palo Santo is a venture capital firm based in Brooklyn, New York, with a team of 32 employees. The company focuses its investments on the burgeoning field of psychedelic-assisted treatments for mental health and addiction. Palo Santo's diversified investment fund targets high growth opportunities within biotech and drug development, healthcare services, and digital health solutions. They seek to support businesses dedicated to providing clinically effective, affordable, and accessible mental health and addiction treatment solutions. Recognizing the potential of psychedelic-assisted treatments, Palo Santo seeks to bridge the gap in institutional capital available within this rapidly evolving ecosystem. The firm focuses on partnering with passionate, experienced, and ethical management teams who are developing innovative solutions to address a wide range of conditions, including depression, PTSD, anxiety, OCD, drug and alcohol dependence, chronic pain, Alzheimer's, and inflammatory-related illnesses. For more information about Palo Santo and its investment portfolio, please visit their website at palosanto.vc.